These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors. Choudhury D; Talukdar AD; Chetia P; Bhattacharjee A; Choudhury MD Comb Chem High Throughput Screen; 2016; 19(9):705-713. PubMed ID: 27450181 [TBL] [Abstract][Full Text] [Related]
9. Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in Ranjitkar S; Jones AK; Mostafavi M; Zwirko Z; Iartchouk O; Barnes SW; Walker JR; Willis TW; Lee PS; Dean CR Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420483 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India. Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722 [TBL] [Abstract][Full Text] [Related]
11. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation. Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665 [TBL] [Abstract][Full Text] [Related]
12. Role of MexAB-OprM efflux pump in the emergence of multidrug-resistant clinical isolates of Pseudomonas aeruginosa in Mazandaran province of Iran. Ahmadian L; Haghshenas MR; Mirzaei B; Khalili Y; Goli HR Mol Biol Rep; 2023 Mar; 50(3):2603-2609. PubMed ID: 36626068 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003 [TBL] [Abstract][Full Text] [Related]
14. Catch me if you can: a biotinylated proteoliposome affinity assay for the investigation of assembly of the MexA-MexB-OprM efflux pump from Pseudomonas aeruginosa. Ntsogo Enguéné VY; Verchère A; Phan G; Broutin I; Picard M Front Microbiol; 2015; 6():541. PubMed ID: 26082762 [TBL] [Abstract][Full Text] [Related]
15. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa. Middlemiss JK; Poole K J Bacteriol; 2004 Mar; 186(5):1258-69. PubMed ID: 14973037 [TBL] [Abstract][Full Text] [Related]
16. Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach. Phan TV; Nguyen VT; Nguyen CH; Vu TT; Tran TD; Le MT; Trinh DT; Tran VH; Thai KM J Biomol Struct Dyn; 2023; 41(22):12503-12520. PubMed ID: 36762699 [TBL] [Abstract][Full Text] [Related]
17. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798 [TBL] [Abstract][Full Text] [Related]
18. The Art of War with Avakh A; Grant GD; Cheesman MJ; Kalkundri T; Hall S Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627724 [No Abstract] [Full Text] [Related]
19. Identification of novel efflux pump inhibitors for Neisseria gonorrhoeae via multiple ligand-based pharmacophores, e-pharmacophore, molecular docking, density functional theory, and molecular dynamics approaches. Jain N; Sk MF; Mishra A; Kar P; Kumar A Comput Biol Chem; 2022 Jun; 98():107682. PubMed ID: 35462198 [TBL] [Abstract][Full Text] [Related]